These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [The analysis of CCR4+/CXCR3+ cell ratio in gastrointestinal cancer patients receiving chemotherapy or immunotherapy].
    Author: Sakuyama R, Aruga A, Kuramochi H, Matsushita N, Kotera Y, Takeshita S, Hayashi K, Yamamoto M.
    Journal: Gan To Kagaku Ryoho; 2008 Nov; 35(12):2259-61. PubMed ID: 19106589.
    Abstract:
    We investigated the expression of CCR4 and CXCR3 with the peripheral blood lymphocytes in 31 gastrointestinal cancer patients who received either chemotherapy or immunotherapy. The expressions of CXCR3 were 6.8% in the patients received chemotherapy and 24.2% in the patients received immunotherapy. The expressions of CCR4 were 25.6% in the patients received chemotherapy and 15.4% in the patients received immunotherapy. The ratio of CCR4+/CXCR3+ cells was 4.45 in chemotherapy and 0.72 in immunotherapy. These results suggested that it was the Th2 dominant condition in the patients received chemotherapy and the Th1 dominant condition in the patients received immunotherapy.
    [Abstract] [Full Text] [Related] [New Search]